ABCLNasdaq Canada
Market cap
$2.042 B
$6.93 +6.13%
Close of 7 Aug 2026
Revenue
$75.1M
#2614 by revenue
Earnings
-$146.4M
Loss-making
Shares outstanding
306,611,466
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for AbCellera Biologics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.